← Back to Dashboard
Regulatory & Optimization Focus

Process Development

Origin Data Source OpenAlex
Analysis Computed Apr 15, 2026
AI Synthesis & Market Narrative
The biopharmaceutical sector is intensely focused on manufacturing optimization and navigating complex regulatory frameworks like CMC and ICH Q12 for EU submissions. This drives significant market demand for specialized training and growth in Biopharmaceutical CMO & CRO services, particularly in process development.
Correlated Linguistic Patterns
["manufacturing optimization" "dual myostatin assets" "Chemistry Manufacturing and Controls (CMC) Package" "Veterinary Pharmaceutical Products" "EU registration" "ICH Q12" "Pharmaceutical Product Lifecycle Management" "Biopharmaceutical CMO & CRO Market" "process development"]
Driving Media Context
GlobeNewswire • Apr 13, 2026

Developing the Chemistry, Manufacturing and Controls (CMC) Package for Veterinary Pharmaceutical Products in the EU Training Course (ONLINE EVENT: May 7, 2026)

The main market opportunity lies in offering specialized courses that aid veterinary pharmaceutical companies in navigating complex and evolving CMC regulati...
GlobeNewswire • Apr 13, 2026

NorthStrive Biosciences Announces U.S. Arrival of EL-32 Working Cell Bank and Initiation of Manufacturing Optimization for Dual Myostatin Assets Targeting Muscle Preservation with GLP-1 Therapies in Collaboration with Modulant Biosciences

NorthStrive Biosciences Announces U.S. Arrival of EL-32 Working Cell Bank and Initiation of Manufacturing Optimization for Dual Myostatin Assets Targeting...
GlobeNewswire • Apr 10, 2026

ICH Q12 Training Course: Advanced Pharmaceutical Product Lifecycle Management in Practice (ONLINE EVENT: July 8th, 2026)

The market opportunities lie in leveraging ICH Q12's harmonized framework to enhance post-approval CMC change management. By implementing practical tools lik...
GlobeNewswire • Apr 10, 2026

Veterinary Pharmaceutical Submissions in the EU Training Course: Key Information to Achieve a Successful Application (ONLINE EVENT: May 18th - May 20th, 2026)

Opportunity exists in streamlining the complex process of obtaining marketing authorisation for veterinary medicines in the EU. By offering intensive trainin...
GlobeNewswire • Apr 9, 2026

Biopharmaceutical CMO & CRO (Analytical, Cell Culture, Clinical Development, Fill-Finish, Formulation, Preclinical Development, Process Development) Market Research & Global Forecast Report 2026-2032

Key opportunities include strategic partnerships, digital capabilities, supply chain resilience, modular facilities, flexible commercial models, and regional...
Royal Society of Chemistry • Apr 9, 2026

Advanced pathways for hydrogen production: a collective view from a technical experts meeting

Energy Environ. Sci., 2026, Advance ArticleDOI: 10.1039/D5EE04503G, Perspective Open Access &nbsp This article is licensed under a Creative Commons Attributi...
Royal Society of Chemistry • Apr 8, 2026

Sustainability Impact for Extraction (SIX Score): from Concepts and Principles to Impact-based Metric for Green Extraction Assessment

Green Chem., 2026, Accepted ManuscriptDOI: 10.1039/D5GC07041D, Paper Open Access &nbsp This article is licensed under a Creative Commons Attribution-NonComme...
GlobeNewswire • Apr 8, 2026

Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit

Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit ...
GlobeNewswire • Apr 7, 2026

Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit

– Novel lipid nanoparticles entirely built on the POZ Platform that overcome the PEG immunogenicity dilemma – Design & synthesis of novel ionizable...
GlobeNewswire • Mar 30, 2026

Silvaco Announces Strategic Partnership with APEC to Advance Silicon Carbide Power Device Development

APEC Expands Adoption of Silvaco's Victory™ TCAD and EDA Solutions to Accelerate Next-Generation Power Semiconductor Innovation APEC Expands Adoption of Silv...